Co-expression network analysis and genetic algorithms for gene prioritization in preeclampsia

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Tejera, Eduardo ^a   Bernardes, João ^b,c   Rebelo, Irene ^a,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLASSIFICATION; CONTROLLED STUDY; ENG GENE; FLNB GENE; FLT1 GENE; GENE; GENE EXPRESSION; GENETIC ALGORITHM; HUMAN; INHA GENE; INHBA GENE; LEP GENE; LYN GENE; MICROARRAY ANALYSIS; NDRG1 GENE; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ALGORITHMS; COMPUTATIONAL BIOLOGY; FEMALE; GENE REGULATORY NETWORKS; HUMANS; PRE-ECLAMPSIA; PREGNANCY; TRANSCRIPTOME;

EID: 84887314151     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-51     Document Type: Article

References (57)

1. Hypertensive disorders of pregnancy. Leeman L, Fontaine P, Am Fam Physician 2008 78 1 93 100 18649616
2. National Collaborating Centre for Women's and Children's Health, Hypertension in pregnancy. The management of hypertensive disorders during pregnancy London (UK): National Institute for Health and Clinical Excellence (NICE); 46. Clinical guideline; no. 107 2010
3. Pre-eclampsia and eclampsia: the disease of theories. Jeffcoate TN, Proc R Soc Med 1966 59 5 397 404 5933114
4. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Sheppard SJ, Khalil RA, Cardiovasc Hematol Disord Drug Targets 2010 10 1 33 52 10.2174/187152910790780096 20041838
5. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y, Placenta 2007 28 5-6 487 497 16860862 (Pubitemid 46593762)
6. Altered global gene expression in first trimester placentas of women destined to develop Preeclampsia. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP, Placenta 2009 30 1 15 24 10.1016/j.placenta. 2008.09.015 19027158
7. Differential placental gene expression in severe preeclampsia. Sitras V, Paulssen RH, Grønaas H, Leirvik J, Hanssen TA, Vårtun A, Acharya G, Placenta 2009 30 5 424 433 10.1016/j.placenta.2009.01.012 19249095
8. Preeclampsia: a bioinformatics approach through protein-protein interaction networks analysis. Tejera E, Bernardes J, Rebelo I, BMC Syst Biol 2012 6 97 10.1186/1752-0509-6-97 22873350
9. NCBI GEO: archive for functional genomics data sets-10 years on. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Holko M, Ayanbule O, Yefanov A, Soboleva A, Nucleic Acids Res 2011 39 1005 D1010 10.1093/nar/gkq1184 21097893
10. ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments. Parkinson H, Sarkans U, Kolesnikov N, Abeygunawardena N, Burdett T, Dylag M, Emam I, Farne A, Hastings E, Holloway E, Kurbatova N, Lukk M, Malone J, Mani R, Pilicheva E, Rustici G, Sharma A, Williams E, Adamusiak T, Brandizi M, Sklyar N, Brazma A, Nucleic Acids Res 2011 39 1002 D1004 10.1093/nar/gkq1040 21071405
11. Evaluation of COMT as a maternal preeclampsia candidate susceptibility gene; assessed by genotyping of the Val158Met polymorphism and by transcriptinal profiling of decidual tissue. Roten LT, Johnson MP, Løset M, Mundal SV, Forsmo S, Skorpen F, Fenstad MH, Dyer TD, Blangero J, Moses EK, Austgulen E, Array Express Database 2011 Ref:E-TABM-682. Last update, June 2011
12. Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia. Eide IP, Isaksen CV, Salvesen KA, Langaas M, Schønberg SA, Austgulen R, Acta Obstet Gynecol Scand 2008 87 3 272 279 10.1080/00016340701763015 18307065 (Pubitemid 351317474)
13. Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Tsai S, Hardison NE, James AH, Motsinger-Reif AA, Bischoff SR, Thames BH, Piedrahita JA, Placenta 2011 32 2 175 182 10.1016/j.placenta. 2010.11.014 21183218
14. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, Haimov-Kochman R, Yeh RF, Overgaard MT, Varki A, Oxvig C, Fisher SJ, Endocrinology 2009 150 1 452 462 18818296
15. affy - analysis of Affymetrix GeneChip data at the probe level. Gautier L, Cope L, Bolstad BM, Irizarry RA, Bioinformatics 2004 20 3 307 315 10.1093/bioinformatics/btg405 14960456 (Pubitemid 38262761)
16. Bioconductor: open software development for computational biology and bioinformatics. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J, Genome Biol 2004 5 10 80 10.1186/gb-2004-5-10- r80 15461798
17. lumi: a pipeline for processing Illumina microarray. Du P, Kibbe WA, Lin SM, Bioinformatics 2008 24 13 1547 1548 10.1093/bioinformatics/btn224 18467348 (Pubitemid 351911712)
18. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Davis S, Meltzer PS, Bioinformatics 2007 23 14 1846 1847 10.1093/bioinformatics/btm254 17496320 (Pubitemid 47250323)
19. Cross-platform comparison of microarray-based multiple-class prediction. Fan X, Shao L, Fang H, Tong W, Cheng Y, PLoS One 2011 6 1 16067 10.1371/journal.pone.0016067 21264309
20. Cross-platform microarray data normalisation for regulatory network inference. Sîrbu A, Ruskin HJ, Crane M, PLoS One 2010 5 11 13822 10.1371/journal.pone.0013822 21103045
21. Empirical comparison of cross-platform normalization methods for gene expression data. Rudy J, Valafar F, BMC Bioinforma 2011 12 467 10.1186/1471-2105-12-467
22. nuID: a universal naming scheme of oligonucleotides for illumina, affymetrix, and other microarrays. Du P, Kibbe WA, Lin SM, Biol Direct 2007 2 16 10.1186/1745-6150-2-16 17540033 (Pubitemid 46947853)
23. Carlson M, hgu133b.db: Affymetrix Human Genome U133 Set annotation data (chip hgu133b) R package version 2.8.0
24. WGCNA: an R package for weighted correlation network analysis. Langfelder P, Horvath S, BMC Bioinforma 2008 9 559 10.1186/1471-2105-9-559
25. Strategies for aggregating gene expression data: the collapseRows R function. Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, Salomon DR, Horvath S, BMC Bioinforma 2011 12 322 10.1186/1471-2105-12-322
26. Adjusting batch effects in microarray expression data using empirical Bayes methods. Johnson WE, Li C, Rabinovic A, Biostatistics 2007 8 118 127 10.1093/biostatistics/kxj037 16632515 (Pubitemid 44906106)
27. Limma: linear models for microarray data. Smyth GK, Bioinformatics and Computational Biology Solutions using R and Bioconductor New York: Springer, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, 2005
28. A general framework for weighted gene co-expression network analysis. Zhang B, Horvath S, Stat Appl Genet Mo B 2005 4 1 17
29. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Langfelder P, Zhang B, Horvath S, Bioinformatics 2007 24 5 719 720 18024473 (Pubitemid 351321220)
30. Comparison of low and high dose ionising radiation using topological analysis of gene coexpression networks. Ray M, Yunis R, Chen X, Rocke DM, BMC Genomics 2012 13 190 10.1186/1471-2164-13-190 22594378
31. Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks. Ray M, Zhang W, BMC Syst Biol 2010 4 136 10.1186/1752-0509-4-136 20925940
32. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Huang DW, Sherman BT, Lempicki RA, Nature Protoc 2009 4 1 44 57
33. Preeclampsia, a disease of the maternal endothelium. Powe CE, Levine RJ, Karumanchi SA, Circulation 2011 123 2856 2869 10.1161/CIRCULATIONAHA.109.853127 21690502
34. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. McElrath TF, Lim KH, Pare E, Rich-Edwards J, Pucci D, Troisi R, Parry S, Am J Obstet Gynecol 2012 207 5 407.e1-7 22981320
35. Biomarkers in pre-eclampsia: a novel approach to early detection of the disease. Masoura S, Kalogiannidis IA, Gitas G, Goutsioulis A, Koiou E, Athanasiadis A, Vavatsi N, J Obstet Gynaecol 2012 32 7 609 616 10.3109/01443615.2012.709290 22943702
36. High leptin level and leptin receptor Lys656Asn variant are risk factors for preeclampsia. Wang S, Qiao FY, Feng L, Genet Mol Res 2013 4 12
37. Hypomethylation of the LEP gene in placenta and elevated maternal leptin concentration in early onset pre-eclampsia. Hogg K, Blair JD, von Dadelszen P, Robinson WP, Mol Cell Endocrinol 2013 367 1-2 64 73 23274423
38. Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia. Guo J, Tian T, Lu D, Xia G, Wang H, Dong M, J Obstet Gynaecol Res 2012 38 7 988 996 10.1111/j.1447-0756.2011.01823.x 22568578
39. Gene expression in first trimester preeclampsia placenta. Founds SA, Terhorst LA, Conrad KP, Hogge WA, Jeyabalan A, Conley YP, Biol Res Nurs 2011 13 2 134 139 10.1177/1099800410385448 21044967
40. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia. Pryor-Koishi K, Nishizawa H, Kato T, Kogo H, Murakami T, Tsuchida K, Kurahashi H, Udagawa Y, BJOG 2007 114 9 1128 1137 10.1111/j.1471-0528.2007.01425.x 17617189 (Pubitemid 47247028)
41. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor. Rohra DK, Zeb A, Qureishi RN, Azam SI, Khan NB, Zuberi HS, Sikandar R, Natl Med J India 2012 25 2 68 73 22686711
42. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Aquilina J, Thompson O, Thilaganathan B, Harrington K, Ultrasound Obstet Gynecol 2001 17 6 477 484 10.1046/j.1469-0705.2001.00382.x 11422967 (Pubitemid 32575095)
43. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC, Obstet Gynecol Surv 2011 66 4 225 239 10.1097/OGX.0b013e3182227027 21756405
44. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. Petraglia F, Luisi S, Benedetto C, Zonca M, Florio P, Casarosa E, Volpe A, Bernasconi S, Genazzani AR, J Clin Endocrinol Metab 1997 82 9 2991 2995 10.1210/jc.82.9.2991 9284732 (Pubitemid 27385661)
45. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, Kurahashi H, Udagawa Y, Reprod Biol Endocrinol 2011 9 107 10.1186/1477-7827-9-107 21810232
46. Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women. Okazaki S, Sekizawa A, Purwosunu Y, Farina A, Wibowo N, Okai T, Obstet Gynecol 2007 110 5 1130 1136 10.1097/01.AOG.0000286761.11436.67 17978129 (Pubitemid 350059420)
47. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia. Choi SJ, Oh SY, Kim JH, Sadovsky Y, Roh CR, Am J Obstet Gynecol 2007 196 1 45.e1-7 17240229
48. Gene selection and sample classification using a genetic algorithm and k-Nearest neighbor method. Li L, Weinberg RC, A Practical Approach to Microarray Data Analysis Kluwer Academic Publishers, Berrar DP, Dubitzky W, Granzow M, 2003 216 229
49. Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: a marker of endothelial activation/damage? Saposnik B, Peynaud-Debayle E, Stepanian A, Baron G, Simansour M, Mandelbrot L, de Prost D, Gandrille S, Thromb Res 2012 129 2 152 157 10.1016/j.thromres.2011.07.023 21824644
50. Alterations of maternal plasma HTRA1 level in preeclampsia complicated by IUGR. Marzioni D, Lorenzi T, Altobelli E, Giannubilo SR, Paolinelli F, Tersigni C, Crescimanno C, Monsurrò V, Tranquilli AL, Di Simone N, Castellucci M, Placenta 2012 33 12 1036 1038 10.1016/j.placenta.2012.09.011 23083999
51. High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling. Yu L, Li D, Liao QP, Yang HX, Cao B, Fu G, Ye G, Bai Y, Wang H, Cui N, Liu M, Li YX, Li J, Peng C, Wang YL, J Clin Endocrinol Metab 2012 97 8 1370 E1379 10.1210/jc.2011-2729 22685232
52. Maternal serum activin a at 11-13 weeks of gestation in hypertensive disorders of pregnancy. Akolekar R, Etchegaray A, Zhou Y, Maiz N, Nicolaides KH, Fetal Diagn Ther 2009 25 3 320 327 10.1159/000235878 19776595
53. Global topological features on cancer proteins in the human interactome. Jonsson PF, Bates PA, Bioinformatics 2006 22 2291 2297 10.1093/bioinformatics/ btl390 16844706 (Pubitemid 44390886)
54. Interactome-transcriptome analysis reveals high centrality of genes differentially expressed in lung cancer tissue. Wachi S, Yoneda K, Wu R, Bioinformatics 2005 21 4205 4208 10.1093/bioinformatics/bti688 16188928 (Pubitemid 41724298)
55. Matrix metalloproteinase 1 in pre-eclampsia and fetal growth restriction: reduced gene expression in decidual tissue and protein expression in extravillous trophoblasts. Lian IA, Toft JH, Olsen GD, Langaas M, Bjørge L, Eide IP, Børdahl PE, Austgulen R, Placenta 2010 31 7 615 620 10.1016/j.placenta.2010.04.003 20452670
56. Preeclampsia is associated with alterations in DNA methylation of genes involved in collagen metabolism. Mousa AA, Cappello RE, Estrada-Gutierrez G, Shukla J, Romero R, Strauss JF 3rd, Walsh SW, Am J Pathol 2012 181 4 1455 1463 10.1016/j.ajpath.2012.06.019 22863954
57. Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. Lian IA, Løset M, Mundal SB, Fenstad MH, Johnson MP, Eide IP, Bjørge L, Freed KA, Moses EK, Austgulen R, Placenta 2011 32 11 823 829 10.1016/j.placenta.2011.08.005 21907405